Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Leading Public Health Groups Seek Expedited Injunctive Relief Against Immunization Schedule Changes, Upcoming ACIP Meeting; Hearing Scheduled Friday, February 13


News provided by

American Academy of Pediatrics; Infectious Diseases Society of America; Massachusetts Public Health Alliance; American Public Health Association; American College of Physicians; Society for Maternal-Fetal Medicine

Jan 12, 2026, 18:13 ET

Share this article

Share toX

Share this article

Share toX

  • Plaintiffs in AAP v. Kennedy will seek to enjoin the February 25-26 ACIP meeting to prevent it from taking place.
  • Plaintiffs will ask the Court to vacate the January 5 changes to the pediatric immunization schedule and restore the childhood schedule to what it was as of April 15, 2025.
  • Plaintiffs will argue both issues in a hearing on plaintiffs' motion for preliminary injunction, scheduled for Friday, February 13.

BOSTON, Jan. 12, 2026 /PRNewswire/ -- A group of medical professional societies, led by the American Academy of Pediatrics (AAP) and including the American Public Health Association (APHA), seek to enjoin the upcoming February 25-26 ACIP meeting and vacate recent changes to the pediatric immunization schedule. A hearing on plaintiffs' preliminary injunction is scheduled for Friday, February 13.

On January 5, the Centers for Disease Control and Prevention (CDC) and the U.S. Department of Health and Human Services (HHS) announced sweeping changes to the childhood vaccine schedule without involving the CDC's Advisory Committee on Immunization Practices (ACIP) and without following the scientific, evidence-based standard process, necessitating immediate legal action.

Plaintiffs will seek an expedited injunction to vacate the changes to the childhood schedule announced on January 5 to prevent further harm and protect evidence-based public health.

Plaintiffs also argue that the current ACIP has repeatedly and consistently relied upon spurious evidence when making vaccine recommendations and, therefore, plaintiffs will seek an injunction to stop the ACIP from meeting and issuing further recommendations based on problematic or misconstrued evidence. 

Plaintiffs will continue to challenge any additional final agency actions that the Department of Health and Human Services (HHS) takes to damage public health through unnecessary, unsupported, and ill-advised changes to the CDC's immunization schedules.

In a January 6, 2026, ruling, the U.S. District Court for the District of Massachusetts denied the government's motion to dismiss and ruled that the Plaintiffs had standing to challenge final agency actions that predated the January 5 schedule change.

Plaintiff and Attorney Statements

Statement from Richard Hughes IV, Epstein Becker Green, Attorney for Plaintiffs: 
"Court intervention is now essential to prevent further harm, protect evidence-based recommendations, and ensure that critical decisions affecting children's health are made transparently and guided by evidence, not ideology. We are confident that we will demonstrate for the court that this administration has acted arbitrarily and capriciously in revisions to the childhood immunization schedule and, furthermore, that the current ACIP will continue this destructive pattern if allowed to continue meeting. The integrity of the vaccine policymaking process is not a technical detail: it's what maintains public trust in vaccination and protects communities across the country."

Andrew D. Racine, MD, PhD, FAAP, President, American Academy of Pediatrics (Lead Plaintiff): 
"Children's health depends on vaccine recommendations based on rigorous, transparent science. Unfortunately, recent decisions by federal officials have abandoned this standard, causing unnecessary confusion for families, compromising access to lifesaving vaccines and weakening community protection.

The American Academy of Pediatrics will continue to champion an evidence-based schedule that protects every child, just like we always have. We ask the Department of Health and Human Services to do the same."

Georges C. Benjamin, MD, Executive Director, American Public Health Association: 
"The ACIP committee is tasked with providing evidence-based guidance to practitioners on the front lines of improving the health of all communities. Disregarding the scientific process to fast-track partisan policy changes through a new vaccine schedule will lead to increased illness and suffering by children and their families. We ask the courts to require the Secretary and the Department of Health and Human Services to adhere to the law and follow the administrative and scientific process that was in place before Secretary Kennedy replaced the qualified ACIP members with conflicted and less qualified people, weakened the national vaccine policy making infrastructure, and radically changed the vaccine schedule for children without evidence for change."

Ronald G. Nahass, MD, MHCM, FIDSA, President, Infectious Diseases Society of America: 
"Drastic changes to the vaccine schedule made without clear scientific justification and a transparent public process are already causing significant confusion for families and clinicians, likely leading to lower vaccination rates and putting children and adults at risk of serious illness, hospitalization and death. Making these changes during a flu season that is already taking the lives of children and many others and has not yet peaked is particularly reckless. America's infectious diseases physicians will continue to stand up for our patients and communities as we fight to stop the Secretary's treacherous march to dismantle the vaccine infrastructure that has kept people healthy for decades." 

Carlene Pavlos, Executive Director, Massachusetts Public Health Alliance: 
"The Massachusetts Public Health Alliance joins our sister plaintiffs in expressing outrage and frustration at the most recent actions of the Department of Health and Human Services in changing the childhood immunization schedule without any of the transparent and scientifically sound process that has been used in the past. Make no mistake, this decision, and the chaos and confusion of the last six months of ongoing attacks on vaccinations, will result in more cases of preventable childhood disease and will cost some children their lives."

Jason M. Goldman, MD, MACP, President, ACP:  
"The American College of Physicians is vehemently opposed to the actions the administration has taken to undermine the scientific integrity of the U.S. vaccine schedule. Their most recent action unilaterally substitutes guidance from other countries that was developed without taking into consideration how those countries' health care systems, social structures, and disease patterns differ from those of the U.S. Abandoning the U.S. evidence-based process is a dangerous and potentially deadly decision for Americans that will lead to preventable morbidity. The U.S. vaccine recommendations should be developed, as they have been for decades, using a rigorous, transparent process and an evidence-to-recommendation framework that examines the best available scientific evidence, and is designed to prevent illness, hospitalizations, outbreaks, and death in this country's large, diverse population with uneven access to care. My patients, and everyone in America, deserve vaccine recommendations that are designed to best meet the needs of our country's population and protect our health."

Sindhu K. Srinivas, MD, MSCE, President, Society for Maternal-Fetal Medicine: 
"SMFM members rely on vaccine recommendations based on rigorous, transparent, evidence-based review by qualified experts. The recent changes to the schedule of recommended childhood vaccinations by HHS and the CDC do not meet this standard and will cause more unnecessary confusion among our patients and the general public. These misguided changes will lead to an increase in the number of preventable illnesses and deaths, not only among children but also among other populations at increased susceptibility, including pregnant people, the elderly, and the immunocompromised. SMFM remains committed to providing our patients with trustworthy vaccination guidance based on objective scientific evidence."

MEDIA CONTACT: Annalise Carol, [email protected]

SOURCE American Academy of Pediatrics; Infectious Diseases Society of America; Massachusetts Public Health Alliance; American Public Health Association; American College of Physicians; Society for Maternal-Fetal Medicine

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Court Rejects HHS's Motion to Dismiss Lawsuit Brought by Leading Public Health Groups Against HHS Immunization Schedule Changes, ACIP Reconstitution

The U.S. District Court for the District of Massachusetts today affirmed that a group of medical professional societies, led by the American Academy...

Leading Medical and Public Health Groups Request Transparency, Evidence Behind Changing ACIP Recommendations in Court Hearing

A group of medical professional societies, led by the American Academy of Pediatrics (AAP), today argued in federal court that the changes to vaccine ...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Infection Control

Infection Control

Legal Issues

Legal Issues

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.